ARTICLE | Company News
FDA Approves Protherics' Digifab
September 4, 2001 7:00 AM UTC
Protherics (LSE: PTI) said its Digifab digoxin antibody was approved to treat digoxin toxicity, a life-threatening arrhythmia that can result from treatment with digoxin, a drug used to treat heart co...